Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccination against La Crosse virus.

J Pavlovic1, J Schultz, H P Hefti

  • 1Institute of Medical Virology, University of Zurich, Switzerland.

Intervirology
|March 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optical and acoustic plasmons in the layered material Sr<sub>2</sub>RuO<sub>4</sub>.

Nature communications·2025
Same author

Differences in Discounting Behavior and Brain Responses for Food and Money Reward.

eNeuro·2024
Same author

How Useful are Mid-Arm and Calf Circumferences to Indicate Reduced Muscle Mass in Order to Recognize GLIM-Defined Malnutrition in Elderly Individuals?

Nigerian journal of clinical practice·2023
Same author

Evolution of European light-duty vehicle CO<sub>2</sub> emissions based on recent certification datasets.

Transportation research. Part D, Transport and environment·2022
Same author

[Painful orbital swelling in a 61-year-old female patient].

Der Internist·2020
Same author

Search for a Narrow Resonance Lighter than 200 GeV Decaying to a Pair of Muons in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2020
Same journal

Formulated curcumin exerts potent anti-influenza activity by inhibition of Akt activation and viral genome replication.

Intervirology·2026
Same journal

Isolation of a Variant of the Felid Herpesvirus 1-Live Attenuated Vaccine Strain F2 from Unvaccinated Cats.

Intervirology·2026
Same journal

Antiviral activity of the chemokine CXCL10 against West Nile virus.

Intervirology·2025
Same journal

Serological Evidence of Bluetongue Virus Serotypes Circulating in Pakistan.

Intervirology·2025
Same journal

Expression of Concern.

Intervirology·2025
Same journal

Genetic and Antigenic Variability in VP4 and VP7 of Group A Human Rotavirus in Yunnan, China, from 2015 to 2020.

Intervirology·2025
See all related articles

A new mouse model lacking a functional interferon-alpha/beta receptor (IFNAR-1) shows promise for DNA vaccine development. This model enables complete protection against lethal viral challenge using DNA vaccines encoding specific viral proteins.

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Effective vaccine development, including DNA vaccines, requires suitable animal models.
  • Many emerging zoonotic viruses lack appropriate animal models for research.
  • Interferon-alpha/beta receptor (IFNAR-1)-deficient mice offer a novel model due to high viral susceptibility.

Purpose of the Study:

  • To establish and validate a small animal model for DNA vaccine evaluation.
  • To assess the efficacy of DNA vaccines encoding specific viral proteins in this new model.
  • To investigate the role of adjuvants in enhancing DNA vaccine responses.

Main Methods:

  • Development of interferon-alpha/beta receptor (IFNAR-1)-deficient mice.
  • DNA vaccination using plasmids encoding viral envelope proteins (G1, G2) or nucleocapsid protein (N).

Related Experiment Videos

  • Assessment of protection against lethal viral challenge in vaccinated mice.
  • Evaluation of interleukin-12 (IL-12) as an adjuvant for DNA vaccines.

    • Main Results:

    • IFNAR-1-deficient mice are highly susceptible to viral infections but mount normal immune responses.
    • A single DNA injection encoding viral envelope proteins G1 and G2 conferred complete protection.
    • DNA vaccination with the nucleocapsid protein N showed limited efficacy.
    • IL-12 as an adjuvant improved survival but its effect was independent of the N protein, suggesting innate immune involvement.

    Conclusions:

    • IFNAR-1-deficient mice represent a valuable small animal model for DNA vaccine research.
    • DNA vaccines targeting viral envelope proteins are effective in this model.
    • IL-12's adjuvant effect highlights the importance of innate immunity, such as NK cells, in vaccine responses.